Key findings

Lacosamide is on par with controlled-release carbamazepine for eliminating seizures in patients with newly diagnosed temporal lobe epilepsy, suggests a post hoc analysis of an international trial reported in the journal Seizure . Lacosamide also tended to have fewer adverse effects.

Implications

Lacosamide may offer a new treatment ...